Literature DB >> 32209363

Gold Nanoparticles in Glioma Theranostics.

Mohammad Norouzi1.   

Abstract

Despite many endeavors to treat malignant gliomas in the last decades, the median survival of patients has not significantly improved. The infiltrative nature of high-grade gliomas and the impermeability of the blood-brain barrier to the most therapeutic agents remain major hurdles, impeding an efficacious treatment. Theranostic platforms bridging diagnosis and therapeutic modalities aim to surmount the current limitations in diagnosis and therapy of glioma. Gold nanoparticles (AuNPs) due to their biocompatibility and tunable optical properties have widely been utilized for an assortment of theranostic purposes. In this Review, applications of AuNPs as imaging probes, drug/gene delivery systems, radiosensitizers, photothermal transducers, and multimodal theranostic agents in malignant gliomas are discussed. This Review also aims to provide a perspective on cancer theranostic applications of AuNPs in future clinical trials.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Glioblastoma; Gold nanoparticles; Imaging; Malignant glioma; Theranostic; Therapy

Mesh:

Substances:

Year:  2020        PMID: 32209363     DOI: 10.1016/j.phrs.2020.104753

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  8 in total

1.  Clearable Nanoparticles for Cancer Photothermal Therapy.

Authors:  Jun Zhao; Xin Long; Min Zhou
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Deep Convolutional Neural Network-Based Brain Magnetic Resonance Imaging Applied in Glioma Diagnosis and Tumor Region Identification.

Authors:  Zhen Chen; Ning Li; Changtao Liu; Shiwei Yan
Journal:  Contrast Media Mol Imaging       Date:  2022-05-24       Impact factor: 3.009

Review 3.  Carbon Ion Radiobiology.

Authors:  Walter Tinganelli; Marco Durante
Journal:  Cancers (Basel)       Date:  2020-10-17       Impact factor: 6.575

4.  CdSe/ZnS Core-Shell-Type Quantum Dot Nanoparticles Disrupt the Cellular Homeostasis in Cellular Blood-Brain Barrier Models.

Authors:  Katarzyna Dominika Kania; Waldemar Wagner; Łukasz Pułaski
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

5.  Formulation and Evaluation of Luteolin-Loaded Nanovesicles: In Vitro Physicochemical Characterization and Viability Assessment.

Authors:  Syed Sarim Imam; Sultan Alshehri; Mohammad A Altamimi; Afzal Hussain; Khaled Hamad Alyahya; Wael A Mahdi; Wajhul Qamar
Journal:  ACS Omega       Date:  2021-12-23

Review 6.  Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature.

Authors:  Badriyah Shadid Alotaibi; Manal Buabeid; Nihal Abdalla Ibrahim; Zelal Jaber Kharaba; Munazza Ijaz; Sobia Noreen; Ghulam Murtaza
Journal:  Int J Nanomedicine       Date:  2021-11-11

Review 7.  Overcoming the blood-brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches.

Authors:  Ksenia Mitusova; Oleksii O Peltek; Timofey E Karpov; Albert R Muslimov; Mikhail V Zyuzin; Alexander S Timin
Journal:  J Nanobiotechnology       Date:  2022-09-15       Impact factor: 9.429

8.  Preparation, Biocompatibility and Antitumor Activity of Nanodelivery System Targeting Breast Cancer Base on a Silica Nanoparticle.

Authors:  Jiuzhou Liu; Shasha Ren; Xiangyu Zhang; Yun Feng; Zhenglun Qiu; Li Ma; Jingwen Huang
Journal:  Onco Targets Ther       Date:  2021-05-25       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.